AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Flucloxacillin: serious hepatic disorders.(Safety and Efficacy Issues)(Brief Article)
Flucloxacillin treatment is very rarely associated with an increased risk of hepatic disorders, namely, hepatitis and cholestatic jaundice. In some patients, almost always those with serious underlying disease, these adverse reactions have been fatal.
The United Kingdom Committee on Safety of Medicines (CSM) has previously advised that:
* The onset of hepatic reactions may be delayed for several weeks (up to 2 months) after treatment with flucloxacillin has stopped.
* These reactions are related neither to the dose nor to the route of administration of flucloxacillin.
* Risk factors include treatment for more than …
-
- Acetylsalicylic acid and Reye's syndrome. (Regulatory and Safety Action).
-
Magazine article from: WHO Drug Information
June 22, 2002
700+ words
-
- Valdecoxib: severe cutaneous reactions.(Safety and Efficacy Issues)
-
Magazine article from: WHO Drug Information
Skalski, Violetta
March 22, 2004
700+ words
-
- Asleep at the Road Safety Wheel
-
News wire article from: Europe Intelligence Wire
February 8, 2013
700+ words
-
- China urges Libya to ensure safety of foreign nationals.
-
Newspaper article from: BBC Monitoring International Reports
February 26, 2011
700+ words
-
- About Food Safety -Polska* tastes good!
-
News wire article from: Europe Intelligence Wire
June 30, 2011
700+ words
